Gross Profit Summary of PetMed Express, Inc.

PetMed Express, Inc.'s latest annual gross profit in 2024 was 78.64 Million USD , up 10.75% from previous year.
PetMed Express, Inc.'s latest quarterly gross profit in 2024 FY was 71.59 Million USD , up 0.81% from previous quarter.
PetMed Express, Inc. reported a annual gross profit of 71.01 Million USD in annual gross profit 2023, down -9.05% from previous year.
PetMed Express, Inc. reported a annual gross profit of 78.07 Million USD in annual gross profit 2022, down -13.2% from previous year.
PetMed Express, Inc. reported a quarterly gross profit of 16.91 Million USD for 2024 Q3, down -15.7% from previous quarter.
PetMed Express, Inc. reported a quarterly gross profit of 22.52 Million USD for 2024 Q1, up 29.59% from previous quarter.

Annual Gross Profit Chart of PetMed Express, Inc. (2024 - 2000)

Historical Annual Gross Profit of PetMed Express, Inc. (2024 - 2000)

Year	Gross Profit	Gross Profit Growth
2024	78.64 Million USD	10.75%
2023	71.01 Million USD	-9.05%
2022	78.07 Million USD	-13.2%
2021	89.94 Million USD	10.71%
2020	81.24 Million USD	-14.76%
2019	95.31 Million USD	-2.55%
2018	97.8 Million USD	23.32%
2017	79.31 Million USD	3.96%
2016	76.29 Million USD	0.03%
2015	76.27 Million USD	-1.74%
2014	77.61 Million USD	0.64%
2013	77.12 Million USD	-3.8%
2012	80.16 Million USD	-4.52%
2011	83.95 Million USD	-8.61%
2010	91.86 Million USD	7.66%
2009	85.32 Million USD	14.97%
2008	74.21 Million USD	14.94%
2007	64.56 Million USD	18.82%
2006	54.33 Million USD	24.47%
2005	43.65 Million USD	14.38%
2004	38.16 Million USD	62.72%
2003	23.45 Million USD	78.63%
2002	13.13 Million USD	260.88%
2001	3.63 Million USD	-35.2%
2000	5.61 Million USD	0.0%

Year	Gross Profit	Gross Profit Growth
2024 Q4	16.28 Million USD	-3.73%
2024 Q3	16.91 Million USD	-15.7%
2024 Q1	22.52 Million USD	29.59%
2024 Q2	20.06 Million USD	-10.94%
2024 FY	71.59 Million USD	0.81%
2023 Q1	19.94 Million USD	2.81%
2023 FY	71.01 Million USD	-9.05%
2023 Q2	18.45 Million USD	-7.48%
2023 Q3	15.23 Million USD	-17.41%
2023 Q4	17.38 Million USD	14.07%
2022 Q1	21.78 Million USD	6.13%
2022 FY	78.07 Million USD	-13.2%
2022 Q2	19.17 Million USD	-11.97%
2022 Q4	19.39 Million USD	9.43%
2022 Q3	17.72 Million USD	-7.56%
2021 Q2	23.01 Million USD	-14.06%
2021 FY	89.94 Million USD	10.71%
2021 Q3	19.62 Million USD	-14.75%
2021 Q4	20.52 Million USD	4.58%
2021 Q1	26.78 Million USD	23.51%
2020 Q4	21.68 Million USD	22.54%
2020 Q3	17.69 Million USD	-11.52%
2020 Q1	21.86 Million USD	5.49%
2020 Q2	20 Million USD	-8.5%
2020 FY	81.24 Million USD	-14.76%
2019 Q2	25.25 Million USD	-15.69%
2019 Q1	29.95 Million USD	20.21%
2019 FY	95.31 Million USD	-2.55%
2019 Q4	20.72 Million USD	6.93%
2019 Q3	19.38 Million USD	-23.26%
2018 Q2	23.47 Million USD	-14.51%
2018 Q1	27.46 Million USD	23.97%
2018 Q4	24.91 Million USD	13.56%
2018 FY	97.8 Million USD	23.32%
2018 Q3	21.94 Million USD	-6.54%
2017 Q4	22.15 Million USD	33.12%
2017 Q2	18.06 Million USD	-19.54%
2017 Q1	22.45 Million USD	27.11%
2017 FY	79.31 Million USD	3.96%
2017 Q3	16.64 Million USD	-7.87%
2016 Q4	17.66 Million USD	5.43%
2016 FY	76.29 Million USD	0.03%
2016 Q3	16.75 Million USD	-11.42%
2016 Q2	18.91 Million USD	-17.65%
2016 Q1	22.96 Million USD	35.58%
2015 Q1	23.77 Million USD	36.13%
2015 Q2	18.45 Million USD	-22.35%
2015 Q3	17.1 Million USD	-7.36%
2015 Q4	16.93 Million USD	-0.94%
2015 FY	76.27 Million USD	-1.74%
2014 FY	77.61 Million USD	0.64%
2014 Q2	19.25 Million USD	-19.83%
2014 Q3	16.88 Million USD	-12.27%
2014 Q4	17.46 Million USD	3.4%
2014 Q1	24.01 Million USD	31.69%
2013 FY	77.12 Million USD	-3.8%
2013 Q4	18.23 Million USD	5.94%
2013 Q3	17.21 Million USD	-11.14%
2013 Q2	19.37 Million USD	-13.15%
2013 Q1	22.3 Million USD	17.59%
2012 Q4	18.96 Million USD	10.57%
2012 Q2	19.93 Million USD	-17.32%
2012 FY	80.16 Million USD	-4.52%
2012 Q3	17.15 Million USD	-13.95%
2012 Q1	24.11 Million USD	37.97%
2011 Q4	17.47 Million USD	3.25%
2011 FY	83.95 Million USD	-8.61%
2011 Q3	16.92 Million USD	-24.21%
2011 Q1	27.22 Million USD	35.69%
2011 Q2	22.33 Million USD	-17.98%
2010 Q1	29.28 Million USD	51.26%
2010 Q2	23.68 Million USD	-19.14%
2010 FY	91.86 Million USD	7.66%
2010 Q3	18.82 Million USD	-20.5%
2010 Q4	20.06 Million USD	6.57%
2009 Q1	25.79 Million USD	54.51%
2009 Q2	22.85 Million USD	-11.37%
2009 Q4	19.36 Million USD	11.81%
2009 FY	85.32 Million USD	14.97%
2009 Q3	17.31 Million USD	-24.24%
2008 Q4	16.69 Million USD	10.01%
2008 FY	74.21 Million USD	14.94%
2008 Q3	15.17 Million USD	-22.8%
2008 Q2	19.65 Million USD	-13.4%
2008 Q1	22.69 Million USD	54.07%
2007 FY	64.56 Million USD	18.82%
2007 Q4	14.73 Million USD	15.18%
2007 Q3	12.78 Million USD	-24.43%
2007 Q2	16.92 Million USD	-15.91%
2007 Q1	20.12 Million USD	62.91%
2006 Q4	12.35 Million USD	20.21%
2006 Q3	10.27 Million USD	-30.8%
2006 Q2	14.85 Million USD	-11.91%
2006 Q1	16.85 Million USD	73.13%
2006 FY	54.33 Million USD	24.47%
2005 Q2	11.61 Million USD	-16.22%
2005 Q1	13.86 Million USD	52.47%
2005 Q3	8.44 Million USD	-27.28%
2005 Q4	9.73 Million USD	15.29%
2005 FY	43.65 Million USD	14.38%
2004 Q2	10.22 Million USD	-13.4%
2004 FY	38.16 Million USD	62.72%
2004 Q3	7.05 Million USD	-31.04%
2004 Q1	11.8 Million USD	87.8%
2004 Q4	9.09 Million USD	28.96%
2003 FY	23.45 Million USD	78.63%
2003 Q1	6.26 Million USD	37.5%
2003 Q4	6.28 Million USD	33.5%
2003 Q2	6.2 Million USD	-0.99%
2003 Q3	4.7 Million USD	-24.06%
2002 Q1	1.91 Million USD	43.15%
2002 Q4	4.55 Million USD	27.12%
2002 Q3	3.58 Million USD	16.27%
2002 Q2	3.08 Million USD	61.1%
2002 FY	13.13 Million USD	260.88%
2001 Q2	850.09 Thousand USD	1.97%
2001 FY	3.63 Million USD	-35.2%
2001 Q1	833.66 Thousand USD	9.69%
2001 Q3	618.78 Thousand USD	-27.21%
2001 Q4	1.33 Million USD	115.93%
2000 FY	5.61 Million USD	0.0%
2000 Q4	760 Thousand USD	0.0%

Peer Gross Profit Comparison of PetMed Express, Inc.

Name	Gross Profit	Gross Profit Difference
CannBioRx Life Sciences Corp.	-105.67 Thousand USD	74524.414%
BIMI International Medical Inc.	1.94 Million USD	-3933.334%
China Jo-Jo Drugstores, Inc.	31.1 Million USD	-152.818%
Harrow Health, Inc. 8.625% Senior Notes due 2026	90.55 Million USD	13.147%
Harrow Health, Inc. 11.875% Senior Notes due 2027	90.55 Million USD	13.147%
Leafly Holdings, Inc.	37.45 Million USD	-110.002%
Leafly Holdings, Inc.	37.45 Million USD	-110.002%
LifeMD, Inc.	126.01 Million USD	37.588%
LifeMD, Inc.	126.01 Million USD	37.588%
TRxADE HEALTH, Inc.	2.59 Million USD	-2926.952%
Walgreens Boots Alliance, Inc.	26.52 Billion USD	99.703%

Global Stocks Search

PetMed Express, Inc. (PETS)

Gross Profit Summary of PetMed Express, Inc.

Annual Gross Profit Chart of PetMed Express, Inc. (2024 - 2000)

Historical Annual Gross Profit of PetMed Express, Inc. (2024 - 2000)

Peer Gross Profit Comparison of PetMed Express, Inc.